Alligator Bioscience AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2000, the company reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna eller en av dem i förening med Frederiksen, Søren Bregenholt Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall direkt eller genom dotterbolag eller andra intressebolag, bedriva forsknings- och utvecklingsarbete samt tillverkning och handel inom proteinkemiområdet jämte med detta förenlig verksamhet.
In its most recent annual report (2024), Alligator Bioscience AB reported revenue of SEK 0, a decrease of 100% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2024. The bottom line showed a break-even result.
At the end of 2024, equity financed 34.7% of the balance sheet, and current assets covered short-term debt 0.5 times.
Frequently asked questions
What is the Org number of Alligator Bioscience AB?
Alligator Bioscience AB is registered with Bolagsverket / SCB under Org 5565978201.
Who is the CEO of Alligator Bioscience AB?
Søren Bregenholt Frederiksen is the CEO of Alligator Bioscience AB, in role since 2021.
Who is the chairman of Alligator Bioscience AB?
Hans-Peter Albert Ostler chairs the board of Alligator Bioscience AB, in role since 2025.
Where is Alligator Bioscience AB headquartered?
Alligator Bioscience AB's registered address is Scheelevägen 2.
